Back to search

Article

Alcohol induces sorafenib resistance in hepatocellular carcinoma: A Translational Study

2025-07-01

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Alcohol is a major cause of hepatocellular carcinoma (HCC), accounting for 30% of cases worldwide. Sorafenib, a tyrosine kinase inhibitor (TKI), was the standard first-line treatment for advanced HCC until 2021, but sorafenib resistance is common. We explored the impact of chronic alcohol exposure (CAE) on sorafenib response and sought to identify associated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bcd67af0-f15e-5f16-83f7-d9c8b165004f
DOI
10.21203/rs.3.rs-6837338/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alcohol induces sorafenib resistance in hepatocellular carcinoma: A Translational StudyDOI 10.21203/rs.3.rs-6837338/v1
Select a neighboring publication to make it the new centre.